Departments of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States.
Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, United States.
J Proteome Res. 2021 Jan 1;20(1):14-26. doi: 10.1021/acs.jproteome.0c00409. Epub 2020 Nov 30.
Protein -acylation (commonly known as palmitoylation) is a widespread reversible lipid modification, which plays critical roles in regulating protein localization, activity, stability, and complex formation. The deregulation of protein -acylation contributes to many diseases such as cancer and neurodegenerative disorders. The past decade has witnessed substantial progress in proteomic analysis of protein -acylation, which significantly advanced our understanding of -acylation biology. In this review, we summarized the techniques for the enrichment of -acylated proteins or peptides, critically reviewed proteomic studies of protein -acylation at eight different levels, and proposed major challenges for the -acylproteomics field. In summary, proteome-scale analysis of protein -acylation comes of age and will play increasingly important roles in discovering new disease mechanisms, biomarkers, and therapeutic targets.
蛋白质酰化(通常称为棕榈酰化)是一种广泛存在的可逆脂质修饰,在调节蛋白质定位、活性、稳定性和复合物形成方面发挥着关键作用。蛋白质酰化的失调与许多疾病有关,如癌症和神经退行性疾病。过去十年,蛋白质酰化的蛋白质组学分析取得了重大进展,极大地促进了我们对酰化生物学的理解。在这篇综述中,我们总结了富集酰化蛋白或肽的技术,批判性地综述了蛋白质酰化在八个不同水平的蛋白质组学研究,并提出了酰基蛋白质组学领域的主要挑战。总之,蛋白质酰化的蛋白质组学分析已经成熟,并将在发现新的疾病机制、生物标志物和治疗靶点方面发挥越来越重要的作用。